Akebia Therapeutics Inc
Akebia Therapeutics Inc logo
AKBA

Akebia Therapeutics Inc (AKBA)

$0.98610.79%

Market is closed
– opens on 8 PM, 06 Feb 2023
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.870001
Day's Range
$0.994
$0.241
52-Week Range
$2.93
1 month return47.16%
3 month return243.55%
1 year return47.27%
5 year return93.03%

Insights on Akebia Therapeutics Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 126.75M → 48.96M (in $), with an average decrease of 61.4% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 29.27M → -51.86M (in $), with an average decrease of 277.2% per quarter

  • Vs REGN

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 25.7% return, outperforming this stock by 71.5%

  • Vs MRNA

    In the last 3 years, Moderna Inc has given 110.4% return, outperforming this stock by 198.4%

Analyst Recommendation

based on 7 analysts ratings

Hold
0%
Buy
57%
Hold
42%
Sell

Based on 7 Wall street analysts offering stock ratings for Akebia Therapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 65.31%

Current

$0.99

Target

$1.63

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
0
0
0
Hold
4
4
6
Sell
3
3
3
Consensus
HOLD
HOLD
HOLD

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization163.7M
Book Value$0.08
Dividend Share0.0
Dividend Yield0.0%
Earnings Per Share (EPS)-1.6
PEG Ratio0.0
Wall Street Target Price1.63

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)4.12
Enterprise Value13.2M
Enterprise Value/Revenue0.04
Enterprise Value/Ebitda-0.13

Technicals

Beta0.88
50 Day MA0.5
200 Day MA0.4

Institutional Holdings

Vanguard Group Inc

7.17%

Acadian Asset Management LLC

4.07%

SATTER MANAGEMENT CO., L.P.

2.53%

BlackRock Inc

2.33%

Millennium Management LLC

1.89%

Renaissance Technologies Corp

1.64%

Company Information

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts.
OrganizationAkebia Therapeutics Inc
Employees426
CEOMr. John P. Butler MBA
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Akebia Therapeutics Inc share price today?

Can Indians buy Akebia Therapeutics Inc shares?

How can I buy Akebia Therapeutics Inc shares from India?

Can Fractional shares of Akebia Therapeutics Inc be purchased?

What are the documents required to start investing in Akebia Therapeutics Inc stocks?

What are today’s High and Low prices of Akebia Therapeutics Inc?

What are today’s traded volumes of Akebia Therapeutics Inc?

What is today’s market capitalisation of Akebia Therapeutics Inc?

What is the 52 Week High and Low Range of Akebia Therapeutics Inc?

How much percentage Akebia Therapeutics Inc is down from its 52 Week High?

How much percentage Akebia Therapeutics Inc is up from its 52 Week low?

What are the historical returns of Akebia Therapeutics Inc?

Who is the Chief Executive Officer (CEO) of Akebia Therapeutics Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*